Koers HH Biotechnology Holdings Company
Aandelen
HHBT
US40423K1007
onroerend goed ontwikkeling & transacties
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0003 USD | -.--% | -.--% | -.--% |
Omzet 2014 | 7,99 mln. 7,47 mln. | Omzet 2015 | 7,99 mln. 7,47 mln. | Marktkapitalisatie | 45,7 mln. 42,74 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -4 mln. -3,74 mln. | Nettowinst (verlies) 2015 | 2 mln. 1,87 mln. | EV/omzet 2014 | 2,07 x |
Nettoschuld 2014 | 12,44 mln. 11,64 mln. | Nettoliquiditeiten 2015 | 5,19 mln. 4,85 mln. | EV/omzet 2015 | 5,07 x |
K/w-verhouding 2014 |
-0,95
x | K/w-verhouding 2015 |
18,1
x | Werknemers | 121 |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 99,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 09-09-16 |
Li Rong Wang
DFI | Director of Finance/CFO | 61 | 09-09-16 |
Liang Zou
COO | Chief Operating Officer | 44 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 09-09-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 4,22K | |
+36,16% | 27,29 mld. | |
-13,74% | 26,65 mld. | |
+25,00% | 26,56 mld. | |
-0,71% | 23,73 mld. | |
+44,49% | 22,46 mld. | |
+2,78% | 19,61 mld. | |
+1,45% | 18,04 mld. | |
+28,54% | 16,12 mld. | |
-14,80% | 14,69 mld. |